Case Studies in Dry Eye Management: Appropriate Treatment-De -

Name: Case Studies in Dry Eye Management: Appropriate Treatment-Decisions for Your Patients
Duration: 1 h 3 min 24 s
Description: This educational activity is supported by an independent medical educational grant from Shire.

Media formats available:

Details

Presenters

Overview
This educational activity is supported by an independent medical educational grant from Shire.
Learning Objectives
Upon completion of this activity, the participant should be able to: • Discuss the prevalence of dry eye disease and the related signs and symptoms of patients. • Develop a differential diagnosis for patients with complaints of dry eye. • Propose an individualized treatment plan for patients using current U.S. Food and Drug Administration-approved therapies. • Evaluate how dry eye disease can complicate surgical outcomes and how best to manage dry eye disease in these states. • Differentiate the need for constant maintenance and ongoing ophthalmic care for the various dry eye disease treatments.
Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In cooperation with Evolve Medical Education LLC, the University of Houston College of Optometry has reviewed and endorsed this course. Evolve is an approved COPE Administrator. This course is COPE approved for 1.0 hours of CE Credit for Optometrists. COPE Course ID: 60144-AS COPE Event ID: 116613 COPE Expiration date: December 5, 2021
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
Preeya K. Gupta, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon/Novartis; Allergan/Actavis; Aurea; Biotissue; Carl Zeiss Meditec; Johnson & Johnson Vision; Novabay Pharmaceuticals; Ocular Science; Shire; TearLab; and TearScience. Joseph Tauber, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker's Bureau: Shire. Editorial Support Disclosure Michelle Dalton, Writer, Susan Gallagher-Pecha, director of client services and project management, Evolve Medical Education LLC, and Erin Fletcher, MIT, Evolve Medical Education LLC, have no real or apparent conflicts of interest to report. Jaya Kumar, MD, peer reviewer has no conflict of interest to report.
Disclaimer
Off-Label Statement This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Shire.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 12/31/2019

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
MinuteCE®
At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
MinuteCE®
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Closing the Loop: Structured Follow-Up and Patient Communication
Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®
Closing the Loop: Structured Follow-Up and Patient Communication
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit